[Federal Register Volume 87, Number 245 (Thursday, December 22, 2022)]
[Notices]
[Pages 78699-78700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 78700]]


    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR22-069: High Impact, 
Interdisciplinary Science in NIDDK in Kidney related Research (RC2 
Clinical Trial Optional).
    Date: February 15, 2023.
    Time: 2:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
Diabetes and Digestive and Kidney Diseases, Democracy II, 6707 
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: December 16, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-27824 Filed 12-21-22; 8:45 am]
BILLING CODE 4140-01-P